DPIIT recognised startup Government of India
Startup India
Rivon Pharmaceutical LLP - pharma in Mehsana, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹14.35 Cr
▼ 42% YoY
Net profit · FY 2024
₹32.99 Lakh
Net margin 2.3%
EBITDA · FY 2024
₹1.53 Cr
EBITDA margin 10.7%
Contribution obligation
₹50 Lakh
As per LLP agreement
Open charges
₹38.9 Lakh
Secured borrowings
LLP age
8 yrs
Est. 2018
Employees · EPFO
34
Provident fund records
Designated partners
5
As per MCA filings
About Rivon Pharmaceutical LLP
Data last updated:
Rivon Pharmaceutical LLP is a limited liability partnership (LLP) based in Mehsana, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 February 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAL-9120. Its GSTIN is 24AAXFR3824N1ZH (Gujarat).
The LLP has a total obligation of contribution of ₹50 Lakh. It is led by designated partners including Vimarshkumar Patel Jagdishbhai and Mrugeshkumar Shantilal Desai.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Kamla Amrut Plot No 33 Indrad Kadi, Mehsana, Gujarat, India – 382715.
As per the financials filed for FY 2024, the LLP reported a revenue of ₹14.35 Cr, a decline of 42% compared to the previous year. For the same year it recorded a net profit of ₹32.99 Lakh (net margin 2.3%) and EBITDA of ₹1.53 Cr (EBITDA margin 10.7%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 126% over five years.
The LLP has about 34 employees on its provident fund (EPFO) records.
The LLP is associated with 1 brand: Rivon Pharmaceuticals. As per MCA filings, the LLP has open charges of ₹38.9 Lakh on record.
Rivon Pharmaceutical LLP is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-14-0010898). For more details, the LLP can be reached via its website rivonpharma.com.
Company details
LLPIN AAL-9120
Incorporation Date 02 February 2018
Total Obligation of Contribution ₹50 Lakh
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-GJ-14-0010898
Key People
Vimarshkumar Patel Jagdishbhai Designated Partner Mrugeshkumar Shantilal Desai Designated Partner Hardikkumar Manubhai Patel Designated Partner Recognitions & Rankings of Rivon Pharmaceutical
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-14-0010898
Contact details
Rivon Pharmaceutical LLP's registered office is in Mehsana, Gujarat. Its website is rivonpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressKamla Amrut Plot No 33 Indrad Kadi, Mehsana, Gujarat, India – 382715
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rivon Pharmaceutical LLP, buy the company report.
Comprehensive company report
Rivon Pharmaceutical LLP - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Rivon Pharmaceutical operates one associated brand: Rivon Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company focused on developing and commercializing products for medical needs. | rivonpharma.com |
Financials of Rivon Pharmaceutical LLP
FY 2025 filings availableRivon Pharmaceutical LLP reported revenue of ₹14.35 Cr (down 42% YoY) for FY 2024.
Revenue · FY 2024
₹14.35 Cr ▼ 42%
Net profit · FY 2024
₹32.99 Lakh margin 2.3%
EBITDA · FY 2024
₹1.53 Cr margin 10.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 42%
3 years · compounded
▲ 11%
5 years · compounded
▲ 126%
EBITDA CAGR growth
1 year
▲ 217%
3 years · compounded
▲ 8%
Revenue fell 42% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 126%. EBITDA rose 217% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | ₹14.35 Cr | ||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹32.99 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 2.3% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Rivon Pharmaceutical LLP, buy the company report.
Designated partners of Rivon Pharmaceutical LLP
Rivon Pharmaceutical has 5 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
Current Designated Partners
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vimarshkumar Patel Jagdishbhai | Designated Partner | 02 Feb 2018 | 8 Years 9 Months | Current |
| Mrugeshkumar Shantilal Desai Also directs: Sanitas Human Health Private Limited, Rivonex Lifescience Private Limited, Remedyrise Healthcare Private Limited and 3 more | Designated Partner | 02 Feb 2018 | 8 Years 9 Months | Current |
| Hardikkumar Manubhai Patel | Designated Partner | 02 Feb 2018 | 8 Years 9 Months | Current |
| Harsh H Vyas | Designated Partner | 02 Feb 2018 | 8 Years 9 Months | Current |
| Amitkumar Jayantilal Patel | Designated Partner | 02 Feb 2018 | 8 Years 9 Months | Current |
Charges & borrowings
Open charges
₹38.9 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Apr 2023 | 101088789 | The Kukarwada Nagarik Sahkari Bank Limited | ₹38.9 Lakh | Open | |
| 26 Apr 2018 | 100238425 | The Kukarwada Nagarik Sahkari Bank Limited | ₹- | Open |
To see the full charge records of Rivon Pharmaceutical LLP, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Rivon Pharmaceutical LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rivon Pharmaceutical LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rivon Pharmaceutical LLP has a workforce of 34 employees on its EPFO records as of Mar 21, 2025, across 1 active EPFO establishment.
Employee count
34
Active EPFO establishments
1
Employee growth
-26.09%
GST
Rivon Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAXFR3824N1ZH | Gujarat | Active | 22 Mar 2018 |
To see the full GST registrations and return filing status of Rivon Pharmaceutical LLP, buy the company report.
Recent activity
Rivon Pharmaceutical LLP has 7 designated partner changes on record since 2018: 5 appointments and 2 cessations. The latest: Kuldip Babulal Chaudhari ceased to be Designated Partner on 15 Feb 2021.
AGM
Rivon Pharmaceutical Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Rivon Pharmaceutical Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with The Kukarwada Nagarik Sahkari Bank Limited amounted to Rs. 38.90 Lakh with Charge ID 101088789 was registered on 17 Apr 2023.
Charges
A charge with The Kukarwada Nagarik Sahkari Bank Limited of Rs. 0.00 registered on 26 Apr 2018 with Charge ID 100238425 was modified on 18 Dec 2021.
Ceased
Kuldip Babulal Chaudhari ceased to be Designated Partner.
Ceased
Prakash Shantilal Desai ceased to be Designated Partner.
Charges
A charge with The Kukarwada Nagarik Sahkari Bank Limited amounted to Rs. 0.00 with Charge ID 100238425 was registered on 26 Apr 2018.
Appointed
Amitkumar Jayantilal Patel was appointed as Designated Partner.
Appointed
Hardikkumar Manubhai Patel was appointed as Designated Partner.
Appointed
Harsh H Vyas was appointed as Designated Partner.
Appointed
Mrugeshkumar Shantilal Desai was appointed as Designated Partner.
Appointed
Vimarshkumar Patel Jagdishbhai was appointed as Designated Partner.
1 earlier event is in the company report.
Frequently asked questions
Rivon Pharmaceutical is an active limited liability partnership based in Mehsana, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 02 February 2018 (8+ years old) and is registered under LLPIN AAL-9120.
Rivon Pharmaceutical has 5 current designated partners:
- Vimarshkumar Patel Jagdishbhai - Designated Partner
- Mrugeshkumar Shantilal Desai - Designated Partner
- Hardikkumar Manubhai Patel - Designated Partner
- Harsh H Vyas - Designated Partner
- Amitkumar Jayantilal Patel - Designated Partner
The latest financial statements of Rivon Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Rivon Pharmaceutical is 24AAXFR3824N1ZH, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Rivon Pharmaceutical is AAL-9120. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Rivon Pharmaceutical was incorporated on 02 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Kuldip Babulal Chaudhari ceased to be Designated Partner on 15 Feb 2021. Prakash Shantilal Desai ceased to be Designated Partner on 15 Feb 2021. Amitkumar Jayantilal Patel was appointed as Designated Partner on 02 Feb 2018. Rivon Pharmaceutical has 7 designated partner changes on record in total.
Yes, Rivon Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Rivon Pharmaceutical is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-14-0010898).
Rivon Pharmaceutical can be reached through the website rivonpharma.com. Its registered office is in Mehsana, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages